Results 11 to 20 of about 70,680 (286)
Risk Factors of Supply Chain in Biopharmaceutical Companies in Iran [PDF]
Pharmaceutical Sciences, 2021 Background: Supply chain risk management can help companies detect potential hazards,mitigate potential risks, and thereby increase supply chain efficiency. The biopharmaceuticalindustry in Iran has a generic-based pharmerging market.
Hadi Abbasian +6 more
doaj +1 more source
Hybrid modeling for biopharmaceutical processes: advantages, opportunities, and implementation
Frontiers in Chemical Engineering, 2023 Process models are mathematical formulations (essentially a set of equations) that try to represent the real system/process in a digital or virtual form.
Harini Narayanan +5 more
doaj +1 more source
The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
Antibodies, 2019 The usefulness of higher-order structural information provided by hydrogen/deuterium exchange-mass spectrometry (H/DX-MS) for the structural impact analyses of chemical and post-translational antibody modifications has been demonstrated in various ...
Felix Kuhne +9 more
doaj +1 more source
A study on the Development of Biopharmaceutical Companies Based on the Context of Big Data [PDF]
BIO Web of Conferences, 2023 Based on the requirements of the computer technology background in the new era, this paper takes Chinese biopharmaceutical enterprises as the research object, outlines the general characteristics of innovation in Chinese biopharmaceutical enterprises ...
Li Weichao
doaj +1 more source
Separations, 2018 Antibody-drug conjugates (ADCs) are promising state-of-the-art biopharmaceutical drugs for selective drug-delivery applications and the treatment of diseases such as cancer.
Filip S. Ekholm +8 more
doaj +1 more source
Microbiology Spectrum, 2014 ABSTRACTPlasmids are currently an indispensable molecular tool in life science research and a central asset for the modern biotechnology industry, supporting its mission to produce pharmaceutical proteins, antibodies, vaccines, industrial enzymes, and molecular diagnostics, to name a few key products.
Duarte Miguel F, Prazeres +1 more
openaire +2 more sources
Human Vaccines & Immunotherapeutics, 2020 “Values-based decision-making” frameworks and models are widely described in the literature in various disciplines, including healthcare settings.
Tatjana Poplazarova +2 more
doaj +1 more source
BioTechniques, 2021 Biopharmaceutical products are of great importance in the treatment or prevention of many diseases and represent a growing share of the global pharmaceutical market.
Camila Hiromi Chiba +4 more
doaj +1 more source
The rise of companies from emerging markets in global health governance: opportunities and challenges [PDF]
, 2014 The article analyses the involvement of pharmaceutical companies from emerging markets in global health governance. It finds that they play a central role as low-cost suppliers of medicines and vaccines and, increasingly, new technologies.
ANNE ROEMER-MAHLER +23 more
core +1 more source
, 2023 Biopharmaceutics, in connection with pharmacokinetics, is the field that investigates and describes everything that happens with a medicinal product and the active substance between the moment of administration, the moment it exerts its action and the moment it is eliminated from the body. Biopharmaceutics connects the physico-chemical properties of an
Frijlink, Henderik +3 more
openaire +2 more sources